Short Interpregnancy IntervalNCT07525362
Short Interpregnancy Interval After One Prior Cesarean Delivery and Risk of Intraoperative Maternal Morbidity
An observational study of Short Interpregnancy Interval, run by Assiut University.
Trial summary
To determine if a short interpregnancy interval following a prior cesarean delivery is associated with an increased risk of intraoperative maternal morbidity (e.g., hemorrhage, visceral injury, prolonged surgery) during the next cesarean delivery. Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Short Interpregnancy Interval
- How many people
- 80 participants
- Where
- No sites listed yet
- Study dates
- Apr 2026to Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Study population: Maternal characteristics to be collected will include: Maternal age, Educational level, Marital status, Gestational diabetes mellitus, Pre-pregnancy hypertension , Gestational hypertension, body mass index at delivery (BMI, calculated as weight in kilograms divided by height in meters squared).
Who may be able to join
- Pregnant women with history of one previous cesarean delivery Women admmitted for delivery by cesarean delivery during the study period Singleton pregnancy
Who cannot join
- uterine malformation coagulation abnormalities, hypertension or diabetes before pregnancy, immune-related diseases, and chronic hepatic, renal orcardiac diseases Twin or multiple pregnancies Miscarriage before 28 weeks of gestation; Current placental previa or accrete and risk of PPH patients with medical morbid condition like diabetes, preeclampsia, hypertension, cardiac, renal diseases or patients having obstetrical conditions
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Diaa El- Din Mohamed Abdel -Aal, Professor contact
About this study
To determine if a short interpregnancy interval following a prior cesarean delivery is associated with an increased risk of intraoperative maternal morbidity (e.g., hemorrhage, visceral injury, prolonged surgery) during the next cesarean delivery.
- Conditions
- Short Interpregnancy Interval
- Keywords
- Short interpregnancy interval after one prior cesarean delivery and risk of intraoperative maternal morbidity
What is being measured
The primary outcome is the main question the study is designed to answer.
Utrine rupture Bladder injury
Measured: 1year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study startApr 2026 (estimated)
- Primary completionApr 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Short Interpregnancy IntervalStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hwayda Refaat, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07525362
- Sponsor's protocol ID
- Short interpregnancy interval
- Status last verified
- Apr 2026
- First submitted
- 7 Apr 2026
- Last updated
- 13 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
1. Wahid N, Ullah I, Bibi H, Ali S, Batool A, Islam L, et al. Obstetric Study to Exploring the Prevalence and Determinants of Cesarean Sections at Timeragra Teaching Hospital Dir Lower. Indus J Biosci Res. 2025;3(2):25- 9. 2. Mazhar T, Ambareen A, Jabeen S. Effects Of Short Inter-Delivery Interval On Mode Of Delivery In Previous One Caesarean Section Cases. Khyber Med Univ J. 2022;14(2):128-31. 3. Umeh UA, Eleje GU, Onuh JU, Nwankwo OT, Ezeome IV, Ajah LO, et al. Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval. Obstet Gynecol Int. 2022;2022(1):8028639. 4. Garg B, Darney B, Pilliod RA, Caughey AB. Long and short interpregnancy intervals increase severe maternal morbidity. Am J Obstet Gynecol. 2021;225(3):331-e1
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Short Interpregnancy Interval After One Prior Cesarean Delivery and Risk of Intraoperative Maternal Morbidity
- ClinicalTrials.gov ID
- NCT07525362
- Acronym / sponsor ID
- Short interpregnancy interval
- Conditions
- Short Interpregnancy Interval
- Keywords
- Short interpregnancy interval after one prior cesarean delivery and risk of intraoperative maternal morbidity
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Apr 2026 (estimated)
- Primary completion
- Apr 2027 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine if a short interpregnancy interval following a prior cesarean delivery is associated with an increased risk of intraoperative maternal morbidity (e.g., hemorrhage, visceral injury, prolonged surgery) during the next cesarean delivery.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Maternal characteristics to be collected will include: Maternal age, Educational level, Marital status, Gestational diabetes mellitus, Pre-pregnancy hypertension , Gestational hypertension, body mass index at delivery (BMI, calculated as weight in kilograms divided by height in meters squared).
Key inclusion criteria (1 listed)
- Pregnant women with history of one previous cesarean delivery Women admmitted for delivery by cesarean delivery during the study period Singleton pregnancy
Key exclusion criteria (1 listed)
- uterine malformation coagulation abnormalities, hypertension or diabetes before pregnancy, immune-related diseases, and chronic hepatic, renal orcardiac diseases Twin or multiple pregnancies Miscarriage before 28 weeks of gestation; Current placental previa or accrete and risk of PPH patients with medical morbid condition like diabetes, preeclampsia, hypertension, cardiac, renal diseases or patients having obstetrical conditions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Utrine rupture Bladder injury
Time frame: 1year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
- Background1. Wahid N, Ullah I, Bibi H, Ali S, Batool A, Islam L, et al. Obstetric Study to Exploring the Prevalence and Determinants of Cesarean Sections at Timeragra Teaching Hospital Dir Lower. Indus J Biosci Res. 2025;3(2):25- 9. 2. Mazhar T, Ambareen A, Jabeen S. Effects Of Short Inter-Delivery Interval On Mode Of Delivery In Previous One Caesarean Section Cases. Khyber Med Univ J. 2022;14(2):128-31. 3. Umeh UA, Eleje GU, Onuh JU, Nwankwo OT, Ezeome IV, Ajah LO, et al. Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval. Obstet Gynecol Int. 2022;2022(1):8028639. 4. Garg B, Darney B, Pilliod RA, Caughey AB. Long and short interpregnancy intervals increase severe maternal morbidity. Am J Obstet Gynecol. 2021;225(3):331-e1
- Individual participant dataSharing planned: No
Related trials for Short Interpregnancy Interval
Recruiting
Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families
Short Interpregnancy Intervals, Maternal Health Disparities
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Diaa El- Din Mohamed Abdel -Aal, Professor contact
Questions about this trial
What is this clinical trial studying?
An observational study of Short Interpregnancy Interval, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hwayda Refaat Sayed, Lecturer (+20, hwayda1997@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Utrine rupture Bladder injury (time frame: 1year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07525362, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.